Clinical Trials Logo

Substance Use Disorders clinical trials

View clinical trials related to Substance Use Disorders.

Filter by:

NCT ID: NCT00551863 Completed - Clinical trials for Substance Use Disorders

Developing Violence Prevention Therapy for Substance Abusers

Start date: June 2004
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this project is to develop and pilot test a violence prevention intervention for men and women in treatment for substance use problems.

NCT ID: NCT00447733 Completed - Anxiety Disorders Clinical Trials

Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders

ROP
Start date: March 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether Integrated Treatment is effective in the treatment of anxiety and/or depression with co-occurring substance use disorders.

NCT ID: NCT00407732 Completed - Hepatitis C Clinical Trials

Overcoming Psychiatric Barriers to the Treatment of Hepatitis C

Start date: January 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and evaluate a 9-month psychosocial intervention that will assist patients with hepatitis C in overcoming barriers that prevent them from becoming appropriate candidates for interferon therapy.

NCT ID: NCT00295412 Completed - Schizophrenia Clinical Trials

The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients

Start date: n/a
Phase: Phase 4
Study type: Interventional

The lifetime of substance use disorders in schizophrenia is close to 50%. Substance abuse in schizophrenia is associated with negative consequences. Unfortunately, there no clear guidelines for the pharmacological treatment of this dual diagnosis population. Preliminary results suggest that second-generation antipsychotic drugs (mainly clozapine) may relieve drug cravings in schizophrenia. We performed a 12-week pilot study to evaluate the impact of quetiapine, a second-generation antipsychotic, on substance abuse parameters, psychiatric symptoms and side effects in patients schizophrenia and comorbid substance use disorders. Our expectation was a 20 % decrease in drug cravings from baseline to end-point.

NCT ID: NCT00288886 Completed - Clinical trials for Substance Use Disorders

Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment

Start date: March 2007
Phase: Phase 2
Study type: Interventional

The Contracts, Prompts, and Social Reinforcement (CPR) intervention was designed to address the continuing care adherence needs of veterans presenting for substance use disorder (SUD) treatment. Final results of our recently completed HSR&D clinical trial suggest CPR meaningfully impacts aftercare adherence and abstinence rates. However, CPR did not impact abstinence rates at earlier follow-up points, other important measures of treatment outcome, or AA/NA support group attendance. Furthermore, the generalizability of CPR to other sites has not been established. Thus, the intervention has been modified and pilot testing of this improved version of CPR, which includes contingent reinforcement of abstinence and improved prompting of AA/NA attendance (CPR+), shows promising results. We are conducting a multi-site randomized clinical trial to examine the effectiveness of CPR+. We recruited 183 veterans seeking residential treatment at the Salem and Jackson VAMCs. Our primary hypothesis is that the CPR group will have higher 1-year abstinence rates compared to the STX group. Our secondary hypotheses are that the CPR will be particularly effective for individuals with co-morbid psychiatric disorders, and that the CPR+ group will remain in AA/NA and in aftercare for a longer duration, have fewer days of substance use, fewer hospitalizations, and lower costs of care. Treatment outcome will be measured 3-, 6-, and 12-months after participants enter treatment and compared to baseline levels. The current study will seek to extend past findings to show longer-term effectiveness of the CPR+ intervention on continuing care adherence and greater impact on treatment outcome. Dissemination and implementation efforts will be ongoing for this brief, inexpensive intervention, which offers an important means to improve participation and outcome for individuals seeking SUD treatment within the VAMC. Data collection and analysis has been completed.

NCT ID: NCT00265564 Completed - Clinical trials for Posttraumatic Stress Disorder

SUPER Study (Substance Use and PTSD Treatment Effectiveness Research Study)

Start date: July 2006
Phase: N/A
Study type: Interventional

This study proposes a prospective program of research that will identify feasible and inexpensive methods to detect and treat comorbid PTSD among VA SUD patients, thereby improving substance abuse treatment outcomes.

NCT ID: NCT00252512 Completed - Clinical trials for Substance Use Disorders

The Effect of a Contingency Management Intervention on Substance Use

REAP
Start date: May 2007
Phase: N/A
Study type: Interventional

Contingency management interventions involve providing a tangible reward for progress toward treatment goals. The purpose of this study is to determine whether a contingency management intervention added to usual care leads to improved attendance and decreased substance use in patients attending outpatient substance use disorders treatment.

NCT ID: NCT00183209 Completed - Clinical trials for Substance Use Disorders

Interventions for HIV+ Mothers With Problem Drinking

Start date: December 2001
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of a 14-session behavioral intervention for HIV-infected and uninfected mothers with problem drinking. The intervention targets alcohol and drug problems, sexual risk behavior, and parenting. We hypothesize that mothers in the 14-session intervention condition will show improvements in alcohol and drug use, sexual risk behavior, and parenting in comparison to the control condition, which receives a one session brief video intervention.

NCT ID: NCT00105729 Completed - Clinical trials for Substance Use Disorders

Substance Abuse Self-Help Group Referral: Outcomes and Services Use

Start date: January 2003
Phase: N/A
Study type: Interventional

Self-help groups (SHGs) have become an important component of the system of care for patients with substance use disorders (SUDs). SUD patients' participation in SHGs has been linked to lower relapse rates and less use of additional treatment services.

NCT ID: NCT00062959 Completed - Clinical trials for Substance Use Disorders

Preventing Problem Behavior Among Middle School Students

Start date: June 1994
Phase: N/A
Study type: Interventional

Problem behaviors such as drug use, violence, and school misconduct increase during adolescence. This study evaluated a program designed to prevent problem behaviors in middle school students; the program includes classroom instruction for students and home instruction for parents.